Nautilus Neurosciences Raises $14.5 Million

Nautilus Neurosciences Inc., a Bridgewater, N.J.-based drug startup focused on neurology, has raised around $14.49 million in Series A funding led by Tailwind Capital Partners, according to a regulatory filing. www.nautilusneurosciences.com